InMed Pharmaceuticals reports net loss of US$10.2M

Mugglehead
By Kathryn TindaleSep 24, 2021, 5:11 pm287 pts
Despite losing more money and expecting that to continue, InMed Pharmaceuticals Inc. (Nasdaq: INM) says it’s been making important progress over the course of the year. In the firm’s annual earnings report ended June 30, it reported a net loss of US$10.2 million, 14.6 per cent more than last year’s US$8.9…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.